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Abstract 
Fibroblast infiltration and collagen deposition result in structural changes in the bowel wall, 
and leads to strictures in intestinal inflammatory disease. While stricture can also occur in 
other contexts, such as malignancy, this review focuses on the surgical treatment of stricture 
secondary to inflammatory bowel disease.  Differentiating the cause of a stricture as 
predominantly inflammation versus established fibrosis can be challenging. While 
inflammatory strictures may be medication responsive, predominantly fibrotic strictures 
usually need surgical intervention.  Both  endoluminal and extraluminal approaches have 
been described. Endoscopic dilatation of strictures is suitable for short segment isolated small 
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bowel strictures. Other options are to surgically divide the stricture but preserve length,  
performing a strictureplasty  or resect the strictured segment. The mesentery is increasingly 
recognised to play a role in recurrence. In a relapsing remitting disease such as Crohn’s 
Disease, preservation of intestinal length is essential and balance is needed between this and 
complete resection to reduce the risk of recurrence. Pre and post-operative involvement of the 
multidisciplinary team is essential to improve outcomes in this challenging clinical scenario.  
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1. Introduction  
Intestinal stricture is an important disease which contributes significant morbidity. The main 
pathologies leading to intestinal stricture are Inflammatory bowel disease (IBD) and cancer. 
There are a myriad of other diseases that can also cause stricturing including diverticular 
disease, radiation enteritis, and anastomotic stricture of the small or large bowel following 
surgical resection. The treatment approach differs depending on the underlying surgical 
pathology. For example, if a stricture is in the context of a malignancy options may include 
curative resection, diversion, palliative stenting or resection. This review will focus on 
stricture in IBD.  
Crohn’s disease (CD) is associated with small bowel stricture. In particular, isolated SB 
disease has been associated with a particularly increased risk of stricture.
1
 In ulcerative colitis 
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(UC), strictures can also be a problem at sites of anastomosis, and in ileal pouches. This 
review will focus on surgical management of stricture in the context of IBD.  
 
2. Physiology and pathology of stricturing in IBD  
Strictures develop in over one in three patients in the first decade of diagnosis of CD.
2
 
Almost 50% of CD patients will undergo surgery within the first 5 years of diagnosis.
3
 
Stricturing in IBD is primarily driven by the infiltration of fibroblasts, smooth muscle cells 
and changes in the composition of the extracellular matrix.
4
 Like many disease processes, 
cellular interaction with the microenvironment is key. The interaction between 
myofibroblasts and the extracellular matrix is essential.
5
 Myofibroblasts taken from human 
samples from strictured areas have been shown to have upregulation of genes that change the 
extracellular matrix and promote deposition of collagen.
5
 Strictures can be inflammatory, 
fibrotic or a mixture between the two.
2
 Differentiating between inflammation and fibrosis can 
be challenging with current preoperative imaging modalities.
6
 
 
3. The mesentery in stricturing CD 
The anatomy of the mesocolon has now been elucidated and the mesentery is recognised to 
play an important role in disease.
7
 In particular, the mesentery can drive disease progression 
in CD.
8
 Differences in the microbiome in lymph nodes in the mesentery have been described 
in Crohn’s Disease compared to UC, which may account for some of the recurrences seen 
with mesenteric preserving surgery.
9
 Dealing with the mesenteric component of disease is 
challenging. In CD, the priority traditionally has been to preserve intestinal length. However, 
preserving diseased mesentery comes at a price of increased risk of recurrence.
10
 This is 
because the mesentery contributes to the inflammatory milieu and the propagation of 
conditions that lead to further disease.
11
 Therefore, equipoise must be found between 
preserving mesentery and intestinal length.  
 
4. Sites of stricturing disease in IBD 
Strictures may affect any part of the luminal gastrointestinal tract. This review will deal with 
strictures of the small intestine primarily, and allude to some instances of stricture of the 
colon or rectum. Strictures may also occur at the site of anastomosis. In particular, ileal-
pouch anal anastomosis is prone to stricturing. Interestingly, following ileocolic resection, 
endoscopic recurrence in the neoterminal ileum has a higher risk of disease progression than 
an isolated anastomotic recurrence.
12
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5. Operative indications 
Stricture is associated with higher rates of primary surgery.
13
 For ileocolic CD evidence 
suggests that biologic agents do not change the course of disease and that surgical 
intervention has a similar outcome to medical therapy. Risk factors for primary surgery 
include long segment strictures.
14
 The current NICE guidelines suggest consideration of early 
surgical resection in those with isolated terminal ileal disease once the risks, alternatives and 
patient’s wishes are considered.
15
 This may change over the coming years, as novel 
therapeutic strategies for medical options to reduce collagen deposition emerge.
16,17
 
However, despite the biologic era, many surgeons would argue that medication may prolong 
the course but not change the need for resection, and indeed early resection may be 
associated with benefits.
18
  
 
6. Preoperative assessment of stricturing CD 
There are a number of options for preoperative planning of stricturing CD. Increasingly, 
automated programming of radiology is allowing automation of detecting CD strictures.
19
 
Involvement of the multidisciplinary team in decision making is key in these cases, with 
NICE guidelines recommending discussion with surgeon/gastroenterologist/patient for 
Crohn’s strictures.
20
 Strictures which are more fibrotic in nature traditionally will need 
surgery, although improved understanding of the cellular process may make it easier to 
understand these pathways and open up more medical options. Preoperative factors are 
important contributors to outcomes after stricturoplasty, including sepsis, albumin, 
intraabdominal abscess and medication use including steroids and biological therapy.
21
 The 
context of surgery is also important, with acute presentations being sub-optimal in regards to 
surgical intervention. ECCO guidelines suggest deferral of surgery where possible when 
patients present with small bowel obstruction in CD, and implementation of conservative 
management. This is permits optimisation and nutritional supplementation prior to surgery.
22
 
In cases where there is concern for ischaemia or perforation, this is not possible however. 
Indeed, in keeping with NELA and NASBO data, delayed surgery in those who inevitably 
need surgery can also have deleterious effects.
23,24
 
 
7. Surgical approaches to small bowel strictures in CD 
Surgical approaches to intestinal structure include resectional and non resectional approaches. 
Resectional approaches include the consideration of whether to resect the mesentery, whereas 
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non-resectional approaches include endoluminal approaches with endoscopy, and operative 
approaches such as stricturoplasty. Both open and minimally invasive options are valid.
25
 
 
7.1 Endoscopic approaches  
Endoscopic balloon dilatation may be used alone or in combination with other modalities of 
treatment.
26
 NICE guidelines suggest consideration of balloon dilatation for isolated short 
straight strictures which are easily reached by colonoscopy.  Duodenal strictures have a lower 
rate of success than strictures elsewhere. Areas away from regions of inflammation are more 
likely to have a successful outcome. Other options include injecting medication directly into 
the stricture endoscopically, or stenting.
27
 Endoscopic balloon dilatation has been shown to 
be associated with a high initial response rate (90%), although similar to surgery, over half 
require reintervention.
28
 Patient selection is important in ensuring a good outcome.
29
 
 
7.2 Strictureplasty  
There are several types of strictureplasty described. Initial techniques for stricturoplasty were 
adapted from previously described techniques for pyloroplasty.
30
 Interestingly, stricturoplasty 
appears to result in some reversal of stricture formation.
31
 Stricturoplasty has been shown to 
result in acceptable long term outcomes, although it does have a higher rate of recurrence 
compared to resection.
32
 For patients with multifocal disease, a combination of stricturoplasty 
and resection may be used.  There are several described techniques for strictureplasty: 
The Heineke-Mikuliz strictureplasty was originally described in the context of CD in a series 
of 9 patients by Lee et al in 1982, having been adapted from the technique described for 
pyloroplasty.
30,33
 It involves bringing healthy tissue from proximal and distal to the lesion to 
create a wider lumen at the lesion by creating a longitudinal incision and closing it 
transversely.
34
 A disadvantage is that geometrical studies have shown it can result 
paradoxically in narrowing of the lumen at these “healthy” proximal and distal sites, and 
hence careful attention to the intervening lumen is needed if doing more than one of these in 
close proximity.
34
 The HM stricturoplasty is only suitable for relatively short strictures.  
The Finney strictureplasty involves what is in essence a side to side anastomosis, and is 
suitable in cases where the stricture is too long for HM.
35,36
 A disadvantage is that this 
technique can result in bacterial overgrowth as a diverticulum is created.   
The Michelassi technique was originally described as an option to treat longer strictures, or 
when there are multiple strictures close together.
37
 It is a side to side isoperistaltic 
stricturoplasty, where the stricture is divided in the middle.
38
 More recently, Michelassi has 
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described a new technique which they have termed the Michelassi II stricturoplasty with is an 
end-to-side-to-side-to-end technique for severe disease where an intervening segment is 
excised to deal with discontinuous bowel loops.
39
 
The d’Hoore technique is also described for patients with a long (>20 cm) terminal ileal 
stricture.
40
 This is a modified side-to-side stricturoplasty of the terminal ileum, which like the 
Michelassi technique is also isoperistaltic.
41
 In this technique, the terminal ileum was divided 
in the middle. The proximal segment is pulled over the distal segment including the 
ileocaecal valve. Interrupted sutures are then used to form a side to side anastomosis. The 
group that described this technique noted an issue with strictures at the proximal inlet and 
then refined the technique by adding a Sasaki modification at this end.
42
 
 
7.3 Diversion 
There are many indications for faecal diversion in IBD. In CD, often it is for perianal 
fistulating disease, or to protect a high risk anastomosis.
15,43
 Faecal diversion may also be 
used in the context of strictures to prevent obstruction. This can be useful e.g. in the context 
of anal stricture. Options for diversion include ileostomy and colostomy.  
 
7.4 Resection  
Not surprisingly, resection results in a lower rate of recurrence than stricturoplasty. Ileocolic 
resection is one of the most common operations in CD. Those with TI strictures often 
undergo ileocolic resection. Recent evidence suggests that including the mesentery in 
ileocolic resection may reduce the risk of recurrence. Strategies to minimise recurrence may 
include a total mesocolic resection for terminal ileal strictures,
10
 or may include an 
anastomosis that excludes the mesentery., e.g. the Kono-S Anastomosis.
44
 A complete 
mesocolic resection involves taking the adjacent involved mesentery using a technique 
similar to that of an oncological resection. This has been shown in case series to be associated 
with a lower rate of recurrence and randomised controlled trials are ongoing.
10
 The Kono-S 
anastomosis is an antimesenteric  functional end to end anastomosis.
44
 
 
7.5 Other Strictures in IBD  
Strictures are not unique to the small bowel in CD, and can also occur in UC either de novo 
or in the post-operative setting.  Large bowel strictures are usually dealt with by resection. 
The options may include a subtotal colectomy or a segmental resection. Stricturoplasty in 
large bowel strictures have also been described but are not routinely performed.
45
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Anal strictures in IBD may be dealt with using an endoscopic technique. A strategy involving 
radial cuts has been described. This has been reported to be possible using a TAMIS 
platform.
46
 Balloon dilatation is also possible. In ileal pouch anal anastomosis (IPAA), the 
mainstay of treatment described has been with dilatation. This may be done endoscopically 
using a balloon dilator or using Hagar dilators.
27, 47
 
 
8. Postoperative care 
Post-operative enhanced recovery pathways and careful attention to post-operative nutrition 
and rehabilitation is important to optimise outcomes. Again, a multidisciplinary approach is 
important. Consideration of current guidelines on restarting medications to prevent 
recurrence and involvement of gastroenterology is important.
48
 
There are a number of other postoperative considerations. For example, it is important to be 
cautious with the use of video capsule endoscopy in those who have had stricturing CD as 
there is a risk of a retained capsule causing obstruction. In CD, it is only recommended in the 
context of negative ileocolonoscopy and imaging.
49
 
 
9. Conclusions 
There are many different factors to consider in planning surgery for stricture in IBD. 
Importantly, the length and anatomy of the stricture, the underlying disease process and the 
overall condition of the patient must be considered. Decision making in these complex cases 
benefits from MDT input. Although surgery may be needed acutely, deferred surgery with 
appropriate preoperative nutrition and planning is preferable where feasible.  
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